Functional Assay
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Functional Assay
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
Functional Assay
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Functional Assay
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
Functional Assay
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Functional Assay
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.
Functional Assay
Binding of LAG-3 (human):Fc (human) (rec.) and EBV-transformed B-cells are incubated with either an anti-MHC class II MAb (10 ug/ml) or LAG-3 (human):Fc (human) (rec.) (10 ug/ml) for 30 minutes. at 4°C in PBS/1% BSA. The cells are then stained for 30 minutes. at 4°C with FITC-labeled goat anti-human Fc antibodies.
Functional Assay
LAG 3 (human):Fc (human) (rec.)-induced dendritic cells (DC) maturation. Method: Immature DCs derived from human monocytes, resuspended at 1x10^6 cells/ml in complete culture medium, are incubated with LAG-3 (human):Fc (human) (rec.) (10ug/ml), LPS (positive control, 5ug/ml) or human IgG1 (isotype-matched negative control, 10ug/ml) for 48 hours. DC maturation induced by LAG-3 (human):Fc (human) (rec.) binding to MHC class II or LPS is assessed by the increased expression of MHC Class II, CD80, CD83, CD86 and CD40.